A familiar laboratory pattern can help clinicians recognize a condition, but its absence does not necessarily exclude every presentation. A historical B12 case series is important for that reason. Its lesson is not that unexplained neurological symptoms should automatically be attributed to B12; it is that selected clinical presentations may require more than a single expected blood abnormality.
What the historical series reported
Lindenbaum and colleagues described 141 consecutive patients with neuropsychiatric abnormalities attributed to cobalamin deficiency. Forty lacked anemia or macrocytosis; within that group, both hematocrit and mean cell volume were normal in 19. Of the 40, one died during the first week and all 39 assessable patients showed neuropsychiatric improvement with treatment. Primary case-series abstract.
The wording matters. Forty did not mean that 40 had both measurements normal. Combining the categories would inflate the specific finding. It is also important that this was a group already selected for abnormalities attributed to deficiency, rather than a random sample of everyone with fatigue, numbness or a normal blood count.
Consequently, the proportions cannot estimate how common B12 deficiency is among people reading an online symptom checklist. They describe the clinical series from which they were calculated.
Why improvement is informative but not randomized evidence
The reported clinical response supports the authors' interpretation of these cases. However, there was no randomized untreated comparison in this account. The series cannot isolate every influence on symptom change, estimate a placebo-adjusted effect or compare competing formulations.
Case evidence can be especially valuable when it identifies a presentation that might otherwise be overlooked. Its value is different from the value of a trial: it expands the range of possibilities that deserve careful evaluation, while leaving questions of frequency and comparative effectiveness unresolved.
The abstract was read for this appraisal; the full individual case histories were not. No additional diagnoses, investigation results or treatment details are reconstructed here. A later publication describing this report should not be counted as a separate group of patients without confirming that it actually is one.
Symptoms alone do not supply the missing diagnosis
Online discussions often move from a recognizable symptom to a confident cause. This series does not support that shortcut. A clinical attribution depends on the combined presentation, investigation and follow-up, not simply on whether a reader recognizes a symptom in the paper.
Likewise, the series should not be used to dismiss a negative trial in a different population. Symptomatic clinical cases and older adults with moderate biochemical deficiency but no relevant clinical signs address different questions. Accurate writing keeps both bodies of evidence available without forcing them into a contradiction.
The vitamin B12 overview provides related form and trial context. This article's distinct contribution is the careful interpretation of an atypical clinical presentation.
Prepared for Serum Research, a commercial supplier. It does not independently authenticate catalog materials, establish a reader's diagnosis or offer a treatment regimen.
Published by Serum Research. Sources checked 2026-10-01. How we review evidence · Send a correction.